Tritiation of proteins and other biomolecules by Powers, James
GEORGIA INSTITUTE OF TECHNOLOGY 
OFFICE OF CONTRACT ADMINISTRATION 
SPONSORED PROJECT INITIATION 
Date: 	2/24/81  
Project Title: 	Tritiation of Proteins and Other Biotolecules 
Project No: -33-J04 
Project Director: Dr. James C. Powers 
Sponsor: 
	DHEW/PHS/NIH - National Institute of General Medical Sciences • 
Agreement Period: From 	4/1/81 Until 3/31/82 (04 Year) 
    
Type Agreement: Grant No. 5 -R01- GM25181-04 
Amount: 
	$ 98,919 New PHS Funds (G-33-J04) 
10,369 GIT Contribution (G-33-358) 
$109,288  
• 
Reports Required: Annual Progress Reports with Continuation Applications; 
Terminal Progress Report upon Grant Expiration 
Sponsor Contact Person (s): 
Contractual Matters  
(thni OCA) 
Ms. Ruth C. Monaghan/Linda V. Glen 
Grants Management Specialist ' 
Office of Associate Director for 
Program Activities 
National Institute of General 
Medical Sciences 
Bethesda, MD 20014 
Phone: (301) 496-7746 
Technical Matters 
Dr. Marvin Cassman 
Program Administrator 
National Institute of General 
Medical Sciences 
Bethesda, MD 20014 
Phone: (301) 496-7463 
NOTE: Follow-On Project to G-33-J03 (03 Year) 
Defense Priority Rating: None 
Assigned to: 	Chemistry 
COPIES TO: 
Project Director 





Security Coordinator (OCA) 
■•••"FtlIME-MMITRatbrifteAl 
(School/120=MA 
Library. Technical Reports Section 
EES Information Office 
EES Reports & Procedures 
Project File (OCA) 
ProjectCode(GTRO 
Other OCA Research Project Coordinator  
GEORGIA INSTITUTE OF TECHNOLOGY 	 OFFICE OF CONTRACT ADMINISTRATION 
SPONSORED PROJECT TERMINATION SHEET 
Date 	6/22/82  
Project Title: • Tritiation of Proteins and Other Biomolecules 
Project No: 	G-33-J04 
Project Director: Dr. James C. Powers 
Sponsor: 	DHEW/PHS/NIH - National Institute of General Medical Sciences 
Effective Termination Date: 3/31/82 (end of 04 year) 
Clearance of Accounting Charges: 	  





inal Invoice and Closing Documents 
❑ Final Fiscal Report 
❑ Final Report of Inventions 
❑ Govt. Property Inventory & Related Certificate 
❑ Classified Material Certificate 
Other  Annual Report of Expenditures due by 6/30/82 





( Schoo l /kRigtomy) 
  
COPIES TO:  
Research Admin. Network 
Research Property Management 
Accounting 
Procurement/EES Supply Services 
Research Security Services 
—Reports-Coordinator 	 
Legal Services (OCA) 
Library 
EES Public Relations (2) 
Computer Input 
Project File 
Other Dr. J. Powers 
FORM OCA 10:781 
PIM MXIMIIMMir 
SECTION IV 
• APPLICANT HtPEAT GRANT NUMBER SHOWN ON PAGE 1 




PRINCIPAL INVESTIGATOR OR PROGRAM DIRECTOR (Last. First, Initial) 
Powers, James C.  
PERIOD COVERED BY THIS REPORT 
THROUGH 
NAME OF ORGANIZATION 
Georgia Institute of Technology 
TITLE (Repeat toe shown in Item 1 on first page) 





I. List all Duplications. not previously mooned. resulting from work supported by this grant (author(s) title page numbers. year. Journal or bo 	. List manuscripts separately as suomined 
lor publication or accepted for publication.
2. Provide two reprints of publications not previously submitted to the awarding unit. 
3. Progress Report. (See instructions) 
1. G.A. Bush, N. Yoshida, M.O. Lively, B.P. Mathur, M. Rust, T.F. Moran, and 
J.C. Powers, "Ion Beam Tritium Labeling of Proteins and Peptides", J. Biol. 
Chem. 256, 1 221 3-1 2221 (1981). 
2. Progress Report. 
Scientific Goals. This research is directed toward the development of a 
general method of tritium labeling of proteins and other molecules of biological 
interest with carefully controlled particle beams composed of T3+ and T2+ ions 
and fast T2 molecules. We have now tritiated over 10 different proteins and 
over 5 different peptides and small molecules. After removing the readily 
exchangeable tritium, we have obtained specific activities of 300-900 Curie/mole 
with proteins and 20-40 Curie/mole with small molecules. The method labels all 
amino acid residues and has worked with every organic molecule which we have 
tried. 
Tritiation Apparatus. A high performance ion beam system for the tritiation 
of proteins has been designed and constructed during the past year. The original 
ion beam apparatus has been kept fully operational and working while the new, high 
performance apparatus has been constructed. This new system 'incorporates several 
major advances which include the following: a) magnetic confinement of the elec-
tron beam to give an intense collimated electron beam, b) separate focussing and 
acceleration system for the ion beam, c) magnetic analysis of the reactant T3 + 
ion beam. With this spatially confined electron beam, we have a very "bright" 
source of ionization which produces an intense well defined ion beam. This on 
beam is accelerated, focussed and passed into a state-of-the-art, high field, Co-
Sm permanent magnet which has been built for momentum (mass) analysis of the 
tritium ion beam. This specially configured magnet incorporates both high trans-
mission and resolution so that only mass selected T3 + ion beams bombard the pro-
tein sample. A small post-acceleration/deceleration and ion beam steering system 
delivers the T 3 + onto the protein sample. Electronic power supplies for the 
electron beam and for ion beam acceleration/focussing have been designed and are 
operational. The flux/cm 2 of ions from our new source is 100 times that of the 
previous system. We are presently involved in the determination of the precise 
geometrical shape of the ion beam as it exits the magnetic field and is focussed 
on the solid sample. In order to facilitate rapid, inexpensive testing and 
modifications of the new system on a day-to-day basis we have used non-radioactive 
deuterium ion beams. Once the optimum experimental parameters for matching of 
intense ion beams to the lyophilized protein sample area have been established, 
tritium will be used and we expect significantly increased incorporation of 
tritium into proteins at non-exchangeable sites. 
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Biochemical Studies. Our first paper on the ion beam tritiation of proteins 
and peptides has recently been published and we describe the tritiation and 
characterization of ribonuclease A, porcine pancreatic elastase, thermolysin, 
soybean trypsin inhibitor, a l -protease inhibitor, and the peptide aldehydes 
leupeptin and antipain. After removal of all readily exchangeable tritium, 
the products were obtained in 32-83% yields with specific radioactivities of 
18-856 Ci/mol. The products were chemically pure and had complete biological 
activity. Simple tritium hydrogen exchange accounts for at least 82;' of the 
reaction pathway with proteins and for 100% of the reaction with the peptide 
aldehydes. Thus the ion beam method is a mild procedure for general tritium 
labeling of fragile protein macromolecules and other sensitive biological 
molecules. 
In the last year, most of our effort has been directed toward the tritiation 
of fibrous and connective tissue proteins and the study of their degradation by 
proteases. We have tritiated elastin, collagen, fibronectin, myosin, actin, and 
fibrinogen. Elastin, collagen and fibrinogen have been purified. The others 
have proven to be difficult to purify and the conditions utilized to date have 
resulted in major losses due to denaturation. We expect to be eventually 
successful with fibronectin and actin, but may not succeed with myosin. The 
rates of degradation of the tritiated proteins by bacterial collagenase, human 
thrombin, human cathepsin G and human leukocyte elastase has been studied. We 
hope that these studies will lead to new protease assays utilizing natural protein 
substrates that have been tritiated by the ion beam tritiation method. 
Specific Objectives for the Coming Year. 
1. Complete the construction and testing of our new high performance 
ion beam tritiation system. 
2. Utilize this system to increase the specific activity of proteins 
and other biomolecules which are tritiated by our method. We would 
like to see a 10-100 fold increase in specific activity to the 
range of 1,000-10,000 Ci/mol. Our eventual goal is 10,000-30,000 
Ci/mol. which is the level of materials produced by chemical synthesis. 
3. Characterize the purity and biological activity of the materials 
produced by the new tritiation apparatus. In particular, we plan 
to investigate racemization of amino acid residues in the protein. 
Racemization is one reaction in which tritium for hydrogen exchange 
could take place and yet have only a subtle effect on the structure 
and conformation of a tritiated protein. We do not believe this 
reaction is taking place to any significant extent during our 
tritiation reaction. However we plan to investigate this possibility 
since one investigator has suggested that our method will not be 
completely accepted by some of the scientific community until we 
prove that racemization is not a significant side reaction. 
4. Complete our studies on the degradation of fibrous and connective 
tissue proteins by proteases and publish the results. 
